跳至主要内容
临床试验/EUCTR2010-018870-19-IT
EUCTR2010-018870-19-IT进行中(未招募)不适用

randomized study for hcv recurrence treatment in liver transplant patients with ribavirin pre-treatment for 8 weeks follwed by stadard therapy (48 weeks) with interferon pegylated and ribavirin vs standard antivirla therapy with pegylated interferon and ribavirin ofr 48 weeks. - PEAR

AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA0 个研究点开始时间: 2010年9月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • HCV-RNA positive
  • High level of transaminases
  • Liver biopsy in keeping wih hcv recurrence
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • liver reject
  • disease of biliary tract
  • hbv infection
  • autoantibodies
  • kidney trnaplant
  • denied agreement consense
  • alcol abuse
  • ischemic cardiopathy
  • age>70 years
  • no compliance to treatment

研究者

发起方
AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA

相似试验